In the case of RA and compared to both healthy controls and patients with osteoarthritis, IL-32 expression was higher in RA patients (30); moreover, the synovial biopsies of RA patients exhibit a reduction of IL-32 upon anti-TNFα treatment. The gene discussed is IL32; the disease is rheumatoid arthritis.